Molecular mechanisms of sigma receptor signaling

NIH RePORTER · NIH · R01 · $324,679 · view on reporter.nih.gov ↗

Abstract

Abstract The sigma-1 receptor is an enigmatic transmembrane receptor in humans that has been implicated in a variety of disease processes, including neurodegenerative disease and heart failure. Recently, the sigma receptor has been identified as a regulator of ion channel and GPCR signaling. Despite the growing recognition of the importance of this protein, very little is known regarding the molecular basis for its activity or its contribution to disease. We will study the sigma receptor using a multifaceted approach to examine structure, pharmacology, and dynamics of this important protein. Initial efforts will focus on the use of X-ray crystallography to probe receptor activation mechanism using conformationally selective antibody fragments. Complementing this work, we will explore the role of oligomerization in sigma receptor function using electron microscopy and other methods, and we will characterize the structural dynamics of the receptor by NMR spectroscopy and computational simulations. In the long term, we aim to establish a detailed molecular understanding of the sigma receptor activity and its role in human health and disease.

Key facts

NIH application ID
9906922
Project number
5R01GM119185-04
Recipient
HARVARD MEDICAL SCHOOL
Principal Investigator
Andrew Kruse
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$324,679
Award type
5
Project period
2017-08-15 → 2021-06-30